Compare NCV & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCV | AIRS |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | 363 |
| Industry | Finance Companies | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.7M | 328.7M |
| IPO Year | N/A | 2021 |
| Metric | NCV | AIRS |
|---|---|---|
| Price | $17.45 | $4.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 81.2K | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 12.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $151,818,000.00 |
| Revenue This Year | N/A | $5.19 |
| Revenue Next Year | N/A | $5.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.02 | $1.51 |
| 52 Week High | $17.53 | $12.00 |
| Indicator | NCV | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 69.30 | 76.98 |
| Support Level | $14.91 | $2.40 |
| Resistance Level | N/A | $6.90 |
| Average True Range (ATR) | 0.27 | 0.41 |
| MACD | 0.03 | 0.18 |
| Stochastic Oscillator | 93.60 | 92.73 |
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.